Legal Opinion
Elan Pharmaceuticals, Inc. v. Mayo Foundation for Medical Education & Research
District Court, N.D. California
Decided June 15, 2000No. 3:99-cv-04464PublishedCited by 3 opinions
1Opinion of the Court
ORDER GRANTING DEFENDANT’S MOTION FOR SUMMARY JUDGMENT OF ANTICIPATION
ALSUP, District Judge.
INTRODUCTION
The issue on defendant’s motion for summary judgment is whether a prior-art patent that discloses a “recipe” for producing transgenic mice, some of which will certainly end up with a particular characteristic and some of which won’t, anticipates claims based on the same recipe but covering only those mice that end up with the particular characteristic.
STATEMENT
A suspected cause of Alzheimer’s disease is the formation of plaque in the brain comprised residue from the break-down of an APP…
2Cases cited7 opinions
- Atlas Powder Company v. E.I. Du Pont De Nemours & Company and Alamo Explosives Company, Inc.Court of Appeals for the Federal Circuit · 1984
- Helifix Limited v. Blok-Lok, Ltd. And William Scott Burns v. Helifix North America Corporation, Third Party CounterclaimCourt of Appeals for the Third Circuit · 2000
- In Re John A. DonohueCourt of Appeals for the Federal Circuit · 1985
- In re OelrichCourt of Customs and Patent Appeals · 1981
- Glaxo Inc. And Glaxo Group Limited v. Novopharm Ltd.Court of Appeals for the Federal Circuit · 1995
2 more not listed; retrieve them via the Exa API.
3Cited by3 opinions
- Elan Pharmaceuticals, Inc. And Athena Neurosciences, Inc. v. Mayo Foundation for Medical Education and ResearchCourt of Appeals for the Federal Circuit · 2003
- Elan Pharmaceuticals, Inc., and Athena Neurosciences, Inc. v. Mayo Foundation for Medical Education and ResearchCourt of Appeals for the Federal Circuit · 2002
- Elan Pharmaceuticals, Inc., and Athena Neurosciences, Inc. v. Mayo Foundation for Medical Education and ResearchCourt of Appeals for the Federal Circuit · 2002